Please check your internet connection and try again.
# Diadzein + Genistein + Palmitoylethanolamide
## Overview
This combination product contains Diadzein, Genistein (isoflavones found in soy), and Palmitoylethanolamide (PEA), an endogenous fatty acid amide. These compounds are often used as dietary supplements for various purported health benefits, including anti-inflammatory, antioxidant, and hormonal effects.
## Primary Indications
There are no FDA-approved indications for this specific combination product. Its use is primarily as a dietary supplement, with claimed benefits for pain management, inflammation, and potentially menopausal symptoms. Evidence supporting these uses, especially for the combination, is limited and often derived from studies on individual components.
## Adult Dosing
Dosing for dietary supplements is highly variable and not standardized. Typical suggested daily doses for individual components can range from:
* **Diadzein/Genistein:** 20-80 mg per day, often divided.
* **Palmitoylethanolamide (PEA):** 300-1200 mg per day, sometimes higher, typically divided.
Specific dosing for this combination product should follow the manufacturer's recommendations on the product label.
## Pediatric Dosing
There is no established or recommended pediatric dosing for this combination product. Its use in children is not supported by clinical evidence.
## Dose Adjustments
No specific dose adjustments for renal or hepatic impairment are established due to its status as a dietary supplement.
## Contraindications
* Hypersensitivity to any component of the product.
* Pregnancy and breastfeeding (safety not established).
* Individuals with hormone-sensitive conditions (e.g., certain cancers) should use isoflavones with caution due to potential estrogenic activity, although evidence is mixed.
## Adverse Effects
Adverse effects are generally mild and uncommon, but may include:
* **GI upset:** Nausea, bloating, diarrhea.
* **Allergic reactions:** Rash, itching.
* **Headache.**
## Key Drug Interactions
* **Hormone therapies:** Isoflavones may potentially interact with estrogen replacement therapy or other hormone-based medications.
* **Blood thinners:** There is a theoretical concern for interaction with anticoagulant or antiplatelet drugs due to isoflavones' potential effects on platelet aggregation, though clinical significance is unclear.
* **CYP450 substrates:** Isoflavones may inhibit or induce certain CYP enzymes, though clinical relevance is not well-established.
## Monitoring
No specific laboratory monitoring is typically required. Patients should be advised to report any new or worsening symptoms to their healthcare provider.
## Clinical Pearls
* This product is a dietary supplement and not a substitute for prescribed medications.
* Efficacy and safety data for this specific combination are limited.
* Individual responses can vary significantly.
* Advise patients to discuss the use of this supplement with their healthcare provider, especially if they have underlying health conditions or are taking other medications.
***
**Disclaimer:** This information is intended for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider to ensure that information is current and appropriate for your specific situation. Verify the most current prescribing information and product details with the manufacturer.
